Kiniksa Pharmaceuticals International (KNSA) P/E ratio

P/E ratio today
72.1×

Kiniksa Pharmaceuticals International (KNSA) trades at 72.1× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 55.0×. Today's figure is 31.0% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
72.1×
P/E ratio, fiscal 2025
55.0×
Highest on record
87.7×fiscal 2023
Lowest on record
5.8×fiscal 2022
Fiscal years on record
32022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Kiniksa Pharmaceuticals International P/E ratio, in more detail

Across the 3 fiscal year-ends on record (2022–2025), the highest was 87.7× in fiscal 2023 and the lowest 5.8× in fiscal 2022. Today's P/E ratio is higher than at 67% of the 3 fiscal year-ends on record; their median is 55.0×.

History · 3 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Kiniksa Pharmaceuticals International P/E ratio, year by year

Kiniksa Pharmaceuticals International (KNSA) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today72.1×—$95.11—
202555.0×—$41.25$0.75
2024——$19.78-$0.60
202387.7× 1,422.2% up$17.54$0.20
20225.8×—$14.98$2.60
2021——$11.77-$2.30
2020——$17.67-$2.61
2019——$11.06-$2.99
2018——$28.09—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on KNSA

Kiniksa Pharmaceuticals International, figure by figure

Kiniksa Pharmaceuticals International (KNSA) overview: price, valuation and scorecardAll health care companies by market value

Kiniksa Pharmaceuticals International P/E ratio: questions and answers

What is Kiniksa Pharmaceuticals International's P/E ratio?

Kiniksa Pharmaceuticals International (KNSA) trades at 72.1× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 55.0×.

Is Kiniksa Pharmaceuticals International's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 67% of the 3 fiscal year-ends on record; their median is 55.0×.

What are the highest and lowest P/E ratio figures on record for Kiniksa Pharmaceuticals International?

Across the 3 fiscal year-ends on record (2022–2025), the highest was 87.7× in fiscal 2023 and the lowest 5.8× in fiscal 2022.

How is Kiniksa Pharmaceuticals International's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Kiniksa Pharmaceuticals International it is on record here for 3 fiscal years, 2022 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/KNSA/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.